clipboard

We offer 1800+ tests in clinical, molecular and anatomic pathology.

FIND A TEST
Doctor

With over 18 subspecialties and 60+ experts, we can help with even the most difficult cases. 

GET STARTED
Blood Draw

Visit one of our 21 specimen collection sites.

SEARCH NOW

NEWS & EVENTS

Dr. Jeffrey Myers Recognized with Ward Burdick Award for Distinguished Service to Pathology

Congratulations to Dr. Jeffrey Myers, A. James French Professor of Diagnostic Pathology and Vice Chair for Clinical Affairs and Quality, on receiving the Ward Burdick Award for Distinguished Service to Pathology from the American Society for Clinical Pathology at their 2024 Annual Meeting.

Dr. Riccardo Valdez installed as the inaugural John G. Batsakis Professor of Pathology

Dr. Riccardo Valdez, professor and director of clinical pathology, strode into the dining hall at the North Campus Research Complex with his wife Alyssa by his side as his long-time mentor, Dr. Jeffrey Warren, professor and former director of clinical pathology, warmly welcomed him.

Pathologists Aid in Patient Understanding and Quality of Care

With the passage of the 21st Century Cures Act in 2021, patients were granted access to their medical test results without delay—often before their physician can review them.

SEE ALL NEWS

Featured Test

 

FGFR Mutation/Translocation


Erdafitinib (Balversa™) is an FGFR-inhibitor that is FDA-approved for the treatment of metastatic urothelial cancers harboring susceptible mutations or translocations involving FGFR2 or FGFR3. 
 

LEARN MORE

NCRC Staff

Featured Test

 

Myeloid NGS Panel

This test is intended for the molecular evaluation of myeloid neoplasms including myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS), myelodysplastic/myeloproliferative neoplasms, acute myeloid leukemias (AML), mastocytosis and myeloid neoplasms with eosinophilia and gene rearrangement.


LEARN MORE

Senior woman thinking

Featured Test

 

TFE3 Rearrangement (FISH)

 Detecting rearrangements involving the TFE3 gene region (Xp11.2) via fluorescence in situ hybridization (FISH) to qualitatively assess for the presence of TFE3 translocations that are associated with certain subtypes of renal cell carcinoma. Testing for TFE3 gene rearrangement may aid in the diagnosis and classification of renal tumors.


LEARN MORE

NCRC Staff

Featured Test

 

NGS Solid Tumor Panel


Molecular testing of solid tumor neoplasms - particularly advanced-stage cancer. This DNA and RNA based, NGS test targets 50 actionable genes (35 mutations, 19 amplifications, 21 - fusions). Requires <1mm2 of tissue (as little as 100 tumor cells) and a low 3% QNS rate. 

 

LEARN MORE

Patient Older Woman Gown

Featured Test

 

PIK3CA Mutation: 

NEW TREATMENT OPTION FOR METASTATIC BREAST CANCER

MLabs offers NGS Solid Tumor Panel and Single gene test to detect PIK3CA for FDA approved therapy alpelisib (Piqray®).


LEARN MORE
 

Older Woman and Girl Hugging Beach

Featured Test

 

NR4A3 (9q22-9q31) Rearrangement (FISH)

NR4A3 encodes an orphan nuclear receptor. Rearrangements of NR4A3 occur in more than 80% of extraskeletal myxoid chondrosarcoma (EMC) as well as in salivary acinic cell carcinoma (AciCC), driving tumorigenesis. 


LEARN MORE

Dr Brown